Production is represented by 135 patent medicines:

• 141 officinal presentations
• 109 hospital presentations (covering 50% of the market).

The production of SIPHAT covers the following currently used forms:

• Dry forms: tablets, bags, capsules.
• Pasty forms: suppositories, ointments, creams.
• Non sterile liquid forms: syrups, drinkable solutions, drinkable phials, products for external use and solutions for hemodialysis.
• Sterile liquid forms: injectable ampoules, perfusable solutions in bags and flasks.

Production material

SIPHAT pursues its policy of investment in the rehabilitation of its production premises and the renovation of its machines adapted to the new technologies in accordance with the standards in effect.

With its leading – edge technology production lines, its machines for filling, sterilizing, packing and its controls, SIPHAT ensures a regular growth for an optimum production capacity responding to its partners’ expectations.